genetic data

Emedgene's constantly updating algorithm highlights genetic variants that could affect a patient's health. 

A group of consumer genetic and personal genomic testing companies have released a set of best practices for handling consumers’ personal genetic data.

23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.

The FTC’s PrivacyCon, an all day event that included presentations and discussions from a number of privacy researchers, one presentation focused on the data privacy risks associated with direct to consumer genomic data services.

Health data platform company BaseHealth raised $3.